Phase 1 Open Label Dose-Escalating Study to Evaluate the Safety, Tolerability and Immunogenity of the Recombinant Plague Vaccine rF1V in Healthy Volunteers

Grants and Contracts Details

StatusFinished
Effective start/end date1/21/05 → 4/30/13

Funding

  • Covalent Group: $30,783.00